Immune targets for chemotherapy-resistant breast cancers identified
Scientists have identified immune cell types that could be targeted to develop specific immunotherapies in chemotherapy-resistant breast cancers.
Sep 26, 2022
0
47
MeSH tree: A15.382.490.555.567.537
Scientists have identified immune cell types that could be targeted to develop specific immunotherapies in chemotherapy-resistant breast cancers.
Sep 26, 2022
0
47
New study data shows that the immuno-oncology drug, atezolizumab (marketed as Tecentriq) is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery. This is according ...
Sep 13, 2022
0
71
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic ...
Sep 12, 2022
0
67
The use of broad-spectrum antibiotics in mice with malignant melanoma, an aggressive form of skin cancer, accelerated their metastatic bone growth, likely because the drugs depleted the mice's intestinal flora and weakened ...
Sep 11, 2022
0
281
Scientists have discovered that the body's own natural killer cells can suppress the immune benefits of therapeutic vaccines, a problem that can affect inoculations against chronic viral infections and cancer.
A new study led by Cardiff University has shed light on how the COVID-19 virus "interferes" with the body's initial immune response to avoid detection.
Jul 19, 2022
0
90